News & Publications Share Print Industry News Biotech Startups Use Models of Human Organs for Drug Discovery The Wall Street Journal April 26, 2023 Read More Featured Story This Startup Just Raised $70 Million To Grow Tiny Tumors That Create Personalized Cancer Treatments Forbes November 17, 2021 Read More Xilis in the News Xilis Announces Formation of its Scientific Advisory Board PR Newswire December 15, 2022 Read More Xilis Aims to Demonstrate Ability of Drug Screening Micro-Tumors to Personalize Cancer Therapy Precision Oncology May 25, 2022 Read More Check out these startups from Pear’s Demo Day (there’s usually a breakout or two in the bunch) TechCrunch October 15, 2021 Read More load more Press Releases Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development PR Newswire February 15, 2023 Read More Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million Business Wire July 13, 2022 Read More Xilis Announces Breast Cancer Oncologist Dr. Daniel F. Hayes to Join Clinical Advisory Board Business Wire June 8, 2022 Read More Xilis Participates in €325MM Oncode-PACT Consortium to Accelerate the Development of Cancer Drugs Business Wire May 3, 2022 Read More Xilis Presents Data at ESMO 2021 Demonstrating Capabilities of MicroOrganoSphere™ Technology for Cancer Drug Screening Business Wire September 20, 2021 Read More Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and … Business Wire July 8, 2021 Read More Publications A path to translation: How 3D patient tumor avatars enable next generation precision oncology ScienceDirect October 20, 2022 Read More Rapid tissue prototyping with micro-organospheres Cell Stem Cell September 13, 2022 Read More Patient-derived micro-organospheres enable clinical precision oncology Cell Stem Cell June 2, 2022 Read More Posters A novel and rapid patient-derived organoid breast cancer platform for precision medicine AACR 2023 April 21, 2023 Read More Refractory colorectal cancer patient derived MicroOrganoSpheres (MOS)TM enables correlation of targeted therapy combination response with clinical outcomes AACR 2023 April 21, 2023 Read More Patient-derived MicroOrganoSpheres (MOS)TM enable precision clinical decision-making for multiple myeloma patients AACR 2023 April 20, 2023 Read More Feasibility of establishing and drug screening patient-derived rectal organoid models from pretreatment rectal cancer biopsies ASCO, GI, 2023 January 19, 2023 Read More Micro-OrganoSpheresTM as a Novel Precision Oncology Platform in Colorectal Cancer ESMO 2021 September 1, 2021 Read More Micro-organospheres: An Automated Platform for Repid Drug Screening in Patient-Derived Breast Cancer Organoids ESMO 2021 September 1, 2021 Read More
